FIELD: microbiology.
SUBSTANCE: glia cells are extracted, seeded, and cell is cultivated to produce monomolecular layer. Then cells are extracted and washed. Total RNA is extracted from them, reverse transcription is carried out, as well as amplification of produced DNA. Genes expression is assessed under action of tested compound.
EFFECT: invention makes it possible to accelerate screening of compounds, to search for new compounds with highest activity, which are potential neuroprotectors.
4 cl, 4 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SCREENING PHARMACOLOGICAL COMPOUNDS ACCORDING TO NEUROPROTECTIVE ACTIVITY | 2009 |
|
RU2383615C1 |
| METHOD OF PRODUCING GLIAL DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS WITH INCREASED EXPRESSION OF BDNF FOR THERAPY OF ISCHEMIC STROKE | 2023 |
|
RU2829361C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULT AND METHOD FOR THERAPY | 2002 |
|
RU2251429C2 |
| METHOD OF PRODUCING GLIAL DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS WITH INCREASED EXPRESSION OF NGF FOR THERAPY OF NEURODEGENERATIVE DISEASES | 2023 |
|
RU2829363C1 |
| METHOD FOR PREPARING A NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM NEURONS AND GLIAL CELLS OBTAINED BY DIRECTIONAL DIFFERENTIATION OF INDUCED HUMAN PLURIPOTENT STEM CELLS | 2018 |
|
RU2690498C1 |
| METHOD FOR SIMULATING TISSUE STRUCTURE OF HUMAN RETINA | 2012 |
|
RU2486603C1 |
| NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM NEURONS AND GLIAL CELLS OBTAINED BY DIRECTED DIFFERENTIATION OF INDUCED HUMAN PLURIPOTENT STEM CELLS | 2018 |
|
RU2690846C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEUROLOGIC DISEASES | 2007 |
|
RU2335296C1 |
| METHOD OF PREPARING HUMAN EMBRYONAL NEURONS PREPARATION FOR CYTOTRANSFUSION | 1998 |
|
RU2146932C1 |
| METHOD FOR ASSESSING NEUROPROTECTIVE PROPERTIES OF VITRO SUBSTANCES AND THE TEST SYSTEM FOR ITS IMPLEMENTATION | 2016 |
|
RU2646446C1 |
